This is a Validated Antibody Database (VAD) review about human MTA1, based on 10 published articles (read how Labome selects the articles), using MTA1 antibody in all methods. It is aimed to help Labome visitors find the most suited MTA1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (D40D1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology MTA1 antibody (CST, 5647) was used in western blot knockout validation on human samples at 1:1000 (fig 4c). Transl Oncol (2022) ncbi
Santa Cruz Biotechnology
mouse monoclonal
  • flow cytometry; mouse; loading ...; fig 5b, 5g, s13a
Santa Cruz Biotechnology MTA1 antibody (Santa Cruz, E-12) was used in flow cytometry on mouse samples (fig 5b, 5g, s13a). Leukemia (2022) ncbi
mouse monoclonal (E-12)
  • flow cytometry; mouse; loading ...; fig 5b, 5g, s13a
Santa Cruz Biotechnology MTA1 antibody (Santa Cruz, E-12) was used in flow cytometry on mouse samples (fig 5b, 5g, s13a). Leukemia (2022) ncbi
mouse monoclonal (A-11)
  • western blot; human; 1:1000; loading ...; fig s2c
Santa Cruz Biotechnology MTA1 antibody (Santa Cruz Biotechnology, sc-17773) was used in western blot on human samples at 1:1000 (fig s2c). Curr Biol (2019) ncbi
mouse monoclonal (A-11)
  • immunohistochemistry - paraffin section; human
Santa Cruz Biotechnology MTA1 antibody (Santa Cruz Biotechnology, A-11) was used in immunohistochemistry - paraffin section on human samples . BMC Gastroenterol (2015) ncbi
mouse monoclonal (E-12)
  • chromatin immunoprecipitation; mouse; 1:1000; fig 2
Santa Cruz Biotechnology MTA1 antibody (Santa Cruz, sc-373765) was used in chromatin immunoprecipitation on mouse samples at 1:1000 (fig 2). Nat Commun (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D40D1)
  • western blot knockout validation; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology MTA1 antibody (CST, 5647) was used in western blot knockout validation on human samples at 1:1000 (fig 4c). Transl Oncol (2022) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology MTA1 antibody (Cell Signaling Technology, 5647) was used in western blot on human samples at 1:1000 (fig 5c). Cancer Res (2021) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; fig 3c
Cell Signaling Technology MTA1 antibody (CST, 5647) was used in western blot on human samples (fig 3c). Nucleic Acids Res (2019) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology MTA1 antibody (Cell Signaling Technology, 5647) was used in western blot on mouse samples (fig 1c). Mol Cell (2018) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; loading ...; fig 6c
Cell Signaling Technology MTA1 antibody (Cell signaling, D40D1) was used in western blot on human samples (fig 6c). J Exp Med (2016) ncbi
domestic rabbit monoclonal (D40D1)
  • western blot; human; 1:1000; fig 2
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 6
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology MTA1 antibody (Cell signaling, 5647) was used in western blot on human samples at 1:1000 (fig 2), in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). Oncotarget (2016) ncbi
Articles Reviewed
  1. Lee A, Pingali S, Pinilla Ibarz J, Atchison M, Koumenis C, Argon Y, et al. Loss of AID exacerbates the malignant progression of CLL. Leukemia. 2022;36:2430-2442 pubmed publisher
  2. Wang W, Ma M, Li L, Huang Y, Zhao G, Zhou Y, et al. MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis. Transl Oncol. 2022;25:101500 pubmed publisher
  3. Zhao Z, Szczepanski A, Tsuboyama N, Abdala Valencia H, Goo Y, Singer B, et al. PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer. Cancer Res. 2021;81:4696-4708 pubmed publisher
  4. Rizzini L, Levine D, Perelis M, Bass J, Peek C, Pagano M. Cryptochromes-Mediated Inhibition of the CRL4Cop1-Complex Assembly Defines an Evolutionary Conserved Signaling Mechanism. Curr Biol. 2019;29:1954-1962.e4 pubmed publisher
  5. Ivanochko D, Halabelian L, Henderson E, Savitsky P, Jain H, Marcon E, et al. Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex. Nucleic Acids Res. 2019;47:1225-1238 pubmed publisher
  6. Bornelöv S, Reynolds N, Xenophontos M, Gharbi S, Johnstone E, Floyd R, et al. The Nucleosome Remodeling and Deacetylation Complex Modulates Chromatin Structure at Sites of Active Transcription to Fine-Tune Gene Expression. Mol Cell. 2018;71:56-72.e4 pubmed publisher
  7. Gay G, Braun L, Brenier Pinchart M, Vollaire J, Josserand V, Bertini R, et al. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-?-mediated host defenses. J Exp Med. 2016;213:1779-98 pubmed publisher
  8. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  9. Kang W, Lee J, Oh S, Lee S, Jung C. Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse. BMC Gastroenterol. 2015;15:2 pubmed publisher
  10. Liu C, Yu Y, Liu F, Wei X, Wrobel J, Gunawardena H, et al. A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing. Nat Commun. 2014;5:5733 pubmed publisher